Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

IRF1-IN-2

🥰Excellent
Catalog No. T203076Cas No. 708245-32-3
Alias IRF1-IN2

IRF1-IN-2 is a small molecule inhibitor of interferon regulatory factor 1 (IRF1) that functions by reducing the binding affinity of IRF1 for the caspase-1 (CASP1) gene promoter. this inhibition subsequently suppresses critical cell death signaling pathways, such as pyroptosis, and provides robust protection against ionizing radiation-induced skin inflammatory damage in preclinical models.

IRF1-IN-2

IRF1-IN-2

🥰Excellent
Purity: 99.85%
Catalog No. T203076Alias IRF1-IN2Cas No. 708245-32-3
IRF1-IN-2 is a small molecule inhibitor of interferon regulatory factor 1 (IRF1) that functions by reducing the binding affinity of IRF1 for the caspase-1 (CASP1) gene promoter. this inhibition subsequently suppresses critical cell death signaling pathways, such as pyroptosis, and provides robust protection against ionizing radiation-induced skin inflammatory damage in preclinical models.
Pack SizePriceAvailabilityQuantity
25 mg$36In Stock
50 mg$55In Stock
100 mg$80In Stock
1 mL x 10 mM (in DMSO)$29In Stock
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Batch Information

Select Batch
Purity:99.85%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
IRF1-IN-2 is a small molecule inhibitor of interferon regulatory factor 1 (IRF1) that functions by reducing the binding affinity of IRF1 for the caspase-1 (CASP1) gene promoter. this inhibition subsequently suppresses critical cell death signaling pathways, such as pyroptosis, and provides robust protection against ionizing radiation-induced skin inflammatory damage in preclinical models.
In vitro
Pretreatment of irradiated HaCaT cells, HELF and WS1 cells with IRF1-IN-2 (20 μM, 12 h) reduced the recruitment of IRF1 to the CASP1 promoter in HaCaT cells (20 Gy) and also attenuated IRF1 activation induced by NSP-10 plasmid transfection in HELF and WS1 cells. [1]
In vivo
Methods: IRF1-IN-2 (100 μg/d, subcutaneous injection, irradiated every other day) was administered to mice with inflammatory skin lesions induced by 35 Gy radiation, and its effects were observed. Results: IRF1-IN-2 has a potential protective effect against inflammatory skin lesions induced by 35 Gy radiation in mice. [1]
SynonymsIRF1-IN2
Chemical Properties
Molecular Weight360.43
FormulaC18H20N2O4S
Cas No.708245-32-3
SmilesO=C(NC1=CC=C(C=C1)S(=O)(=O)N2CCCC2)C=3C=CC=CC3OC
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 105 mg/mL (291.32 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7745 mL13.8723 mL27.7446 mL138.7232 mL
5 mM0.5549 mL2.7745 mL5.5489 mL27.7446 mL
10 mM0.2774 mL1.3872 mL2.7745 mL13.8723 mL
20 mM0.1387 mL0.6936 mL1.3872 mL6.9362 mL
50 mM0.0555 mL0.2774 mL0.5549 mL2.7745 mL
100 mM0.0277 mL0.1387 mL0.2774 mL1.3872 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Sci Citations

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy IRF1-IN-2 | purchase IRF1-IN-2 | IRF1-IN-2 cost | order IRF1-IN-2 | IRF1-IN-2 chemical structure | IRF1-IN-2 in vivo | IRF1-IN-2 in vitro | IRF1-IN-2 formula | IRF1-IN-2 molecular weight